Cross-β polymerization of low complexity sequence domains

Cold Spring Harbor Perspectives in Biology

Volumn 9, Issue 3, 2017, Pages

  Kato, Masato ^a   McKnight, Steven L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

ARTIFACT; HUMAN; METABOLISM; OPEN READING FRAME; POLYMERIZATION; PRION;

ARTIFACTS; HUMANS; OPEN READING FRAMES; POLYMERIZATION; PRIONS; TRANSCRIPTION FACTORS;

EID: 85014627153     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a023598     Document Type: Article

References (58)

1. Altmeyer M, Neelsen KJ, Teloni F, Pozdnyakova I, Pellegrino S, Grofte M, Rask MBD, Streicher W, Jungmichel S, Nielsen ML, et al. 2015. Liquid demixing of intrinsically disordered proteins is seeded by poly (ADP-ribose). Nat Commun 6: 8088.
2. Arvand A, Denny CT. 2001. Biology of EWS/ETS fusions in Ewing’s family tumors. Oncogene 20: 5747–5754.
3. Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW III, Rademakers R, et al. 2013.Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77: 639–646.
4. Aubol BE, Plocinik RM, Hagopian JC, Ma CT, McGlone ML, Bandyopadhyay R, Fu XD, Adams JA. 2013. Parti-tioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases. J Mol Biol 425: 2894–2909.
5. Ballatore C, Lee VM, Trojanowski JQ. 2007. Tau-mediated neurodegeneration in Alzheimer’s disease and related disorders. Nat Rev Neurosc 8: 663–672.
6. Benilova I, Karran E, De Strooper B. 2012. The toxic Ab oligomer and Alzheimer’s disease: An emperor in need of clothes. Nat Neurosci 15: 349–357.
7. Bentmann E, Haass C, Dormann D. 2013. Stress granules in neurodegeneration—Lessons learnt from TAR DNA binding protein of 43 kDa and fused in sarcoma. FEBS J 280: 4348–4370.
8. Blum ES, Schwendeman AR, Shaham S. 2013. PolyQ disease: Misfiring of a developmental cell death program? Trends Cell Biol 23: 168–174.
9. Chen S, Ferrone FA, Wetzel R. 2002. Huntington’s disease age-of-onset linked to polyglutamine aggregation nucleation. Proc Natl Acad Sci 99: 11884–11889.
10. Colwill K, Pawson T, Andrews B, Prasad J, Manley JL, Bell JC, Duncan PI. 1996. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution. EMBO J 15: 265–275.
11. Corden JL, Cadena DL, Ahearn JM Jr, Dahmus ME. 1985. A unique structure at the carboxyl terminus of the largest subunit of eukaryotic RNA polymerase II. Proc Natl Acad Sci 82: 7934–7938.
12. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, et al. 2011. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245–256.
13. Donnelly CJ, Zhang PW, Pham JT, Haeusler AR, Mistry NA, Vidensky S, Daley EL, Poth EM, Hoover B, Fines DM, et al. 2013. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron 80: 415–428.
14. Duncan PI, Stojdl DF, Marius RM, Scheit KH, Bell JC. 1998. The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing. Exp Cell Res 241: 300–308.
15. Egloff S, Dienstbier M, Murphy S. 2012. Updating the RNA polymerase CTD code: Adding gene-specific layers. Trends Genet 28: 333–341.
16. Elbaum-Garfinkle S, Kim Y, Szczepaniak K, Chen CCH, Eckmann CR, Myong S, Brangwynne CP. 2015. The disordered P granule protein LAF-1 drives phase separation into droplets with tunable viscosity and dynamics. Proc Natl Acad Sci 112: 7189–7194.
17. Greenwald J, Riek R. 2010. Biology of amyloid: Structure, function, and regulation. Structure 18: 1244–1260.
18. Guipaud O, Guillonneau F, Labas V, Praseuth D, Rossier J, Lopez B, Bertrand P. 2006. An in vitro enzymatic assay coupled to proteomics analysis reveals a new DNA processing activity for Ewing sarcoma and TAF (II) 68 proteins. Proteomics 6: 5962–5972.
19. Haeusler AR, Donnelly CJ, Periz G, Simko EA, Shaw PG, Kim MS, Maragakis NJ, Troncoso JC, Pandey A, Sattler R, et al. 2014. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature 507: 195–200.
20. Han TW, Kato M, Xie S, Wu L, Mirzaei H, Pei J, Chen M, Xie Y, Allen J, Xiao G, McKnight SL. 2012. Cell-free formation of RNA granules: Bound RNAs identify features and components of cellular assemblies. Cell 149: 768–779.
21. Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics. Science 297: 353–356.
22. Heidemann M, Hintermair C, Voss K, Eick D. 2013. Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription. Biochim Biophys Acta 1829: 55–62.
23. Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, Gitler AD. 2009. TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284: 20329–20339.
24. Kato M, Han TW, Xie S, Shi K, Du X, Wu LC, Mirzaei H, Goldsmith EJ, Longgood J, Pei J, et al. 2012. Cell-free formation of RNA granules: Low complexity sequence domains form dynamic fibers within hydrogels. Cell 149: 753–767.
25. Kim HJ, Kim NC, Wang YD, Scarborough EA, Moore J, Diaz Z, MacLea KS, Freibaum B, Li S, Molliex A, et al. 2013. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495: 467–473.
26. Kwon I, Kato M, Xiang S, Wu L, Theodoropoulos P, Mirzaei H, Han T, Xie S, Corden JL, McKnight SL. 2013. Phosphorylation-regulated binding of RNA polymerase II to fibrous polymers of low-complexity domains. Cell 155: 1049–1060.
27. Kwon I, Xiang S, Kato M, Wu L, Theodoropoulos P, Wang T, Kim J, Yun J, Xie Y, McKnight SL. 2014. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 345: 1139–1145.
28. Lagier-Tourenne C, Baughn M, Rigo F, Sun S, Liu P, Li HR, Jiang J, Watt AT, Chun S, Katz M, et al. 2013. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci 110: E4530–E4539.
29. Lamond AI, Spector DL. 2003. Nuclear speckles: A model for nuclear organelles. Nat Rev Mol Cell Biol 4: 605–612.
30. Lauranzano E, Pozzi S, Pasetto L, Stucchi R, Massignan T, Paolella K, Mombrini M, Nardo G, Lunetta C, Corbo M, et al. 2015. Peptidylprolyl isomerase A governs TARDBP function and assembly in heterogeneous nuclear ribonucleoprotein complexes. Brain 138: 974–991.
31. Lessnick SL, Ladanyi M. 2012. Molecular pathogenesis of Ewing sarcoma: New therapeutic and transcriptional targets. Annu Rev Pathol 7: 145–159.
32. Lin CL, Bristol LA, Jin L, Dykes-Hoberg M, Crawford T, Clawson L, Rothstein JD. 1998. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 20: 589–602.
33. Lin Y, Protter DSW, Rosen MK, Parker R. 2015. Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol Cell 60: 208–219.
34. Majumdar A, Cesario WC, White-Grindley E, Jiang H, Ren F, Khan MR, Li L, Choi EM, Kannan K, Guo F, et al. 2012. Critical role of amyloid-like oligomers of Drosophila Orb2 in the persistence of memory. Cell 148: 515–529.
35. Menegay HJ, Myers MP, Moeslein FM, Landreth GE. 2000. Biochemical characterization and localization of the dual specificity kinase CLK1. J Cell Sci 113: 3241–3253.
36. Mizielinska S, Lashley T, Norona FE, Clayton EL, Ridler CE, Fratta P, Isaacs AM. 2013. C9orf72 frontotemporal lobar degeneration is characterised by frequent neuronal sense and antisense RNA foci. Acta Neuropathol 126: 845–857.
37. Molliex A, Temirov J, Lee J, Coughlin M, Kanagaraj Anderson P, Kim Hong J, Mittag T, Taylor JP. 2015. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell 163: 123–133.
38. Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, et al. 2013. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339: 1335–1338.
39. Newby GA, Lindquist S. 2013. Blessings in disguise: Biological benefits of prion-like mechanisms. Trends Cell Biol 23: 251–259.
40. Nomura T, Watanabe S, Kaneko K, Yamanaka K, Nukina N, Furukawa Y. 2014. Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis. J Biol Chem 289: 1192–1202.
41. Nott TJ, Petsalaki E, Farber P, Jervis D, Fussner E, Plochowietz A, Craggs TD, Bazett-Jones DP, Pawson T, Forman-Kay JD, et al. 2015. Phase transition of a disordered nuage protein generates environmentally responsive membraneless organelles. Mol Cell 57: 936–947.
42. Patel A, LeeHyun O, Jawerth L, Maharana S, Jahnel M, Hein MY, Stoynov S, Mahamid J, et al. 2015. A liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell 162: 1066–1077.
43. Perutz MF, Johnson T, Suzuki M, Finch JT. 1994. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci 91: 5355-5358.
44. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, Schymick JC, Laaksovirta H, van Swieten JC, Myllykangas L, et al. 2011. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257–268.
45. Riordan JF, Wacker WEC, Vallee BL. 1965. N-acetylimidazole: A reagent for determination of “free” tyrosyl residues of proteins. Biochemistry 4: 1758–1765.
46. Roth MB, Murphy C, Gall JG. 1990. A monoclonal antibody that recognizes a phosphorylated epitope stains lampbrush chromosome loops and small granules in the amphibian germinal vesicle. J Cell Biol 111: 2217-2223.
47. Roth MB, Zahler AM, Stolk JA. 1991. A conserved family of nuclear phosphoproteins localized to sites of polymerase II transcription. J Cell Biol 115: 587–596.
48. Sadek H, Hannack B, Choe E, Wang J, Latif S, Garry MG, Garry DJ, Longgood J, Frantz DE, Olson EN, et al. 2008. Cardiogenic small molecules that enhance myocardial repair by stem cells. Proc Natl Acad Sci 105: 6063–6068.
49. Schwartz JC, Ebmeier CC, Podell ER, Heimiller J, Taatjes DJ, Cech TR. 2012. FUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2. Genes Dev 26: 2690–2695.
50. Si K, Choi YB, White-Grindley E, Majumdar A, Kandel ER. 2010. Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 140: 421–435.
51. Timasheff SN, Gorbunoff MJ. 1967. Conformation of proteins. Ann Rev Biochem 36: 13–54.
52. Triezenberg SJ, Kingsbury RC, McKnight SL. 1988a. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev 2: 718–729.
53. Triezenberg SJ, LaMarco KL, McKnight SL. 1988b. Evidence of DNA: Protein interactions that mediate HSV-1 immediate early gene activation by VP16. Genes Dev 2: 730–742.
54. Wickner RB. 1994. Evidence for a prion analog in S. cerevisiae: The [URE3] non-Mendelian genetic elements as an altered URE2 protein. Science 264: 566–569.
55. Wickner RB. 2016. Yeast and fungal prions. Cold Spring Harb Perspect Biol Doi: 10.1101/cshperspect.a023531.
56. Xiang S, Kato M, Wu Leeju C, Lin Y, Ding M, Zhang Y, Yu Y, McKnight SL. 2015. The LC domain of hn RNPA2 adopts similar conformations in hydrogel polymers, liquid-like droplets, and nuclei. Cell 163: 829–839.
57. Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, Margolis J, Peterson M, Markowski TW, Ingram MA, et al. 2011. Non-ATG-initiated translation directed by microsatellite expansions. Proc Natl Acad Sci 108: 260–265.
58. Zu T, Liu Y, Banez-Coronel M, Reid T, Pletnikova O, Lewis J, Miller TM, Harms MB, Falchook AE, Subramony SH, et al. 2013. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc Natl Acad Sci 110: E4968–E4977.